...A. Results: Delivered robust organic revenue growth of 12.7%, well above the mid-single-digit outlook provided on 2Q22 earnings call. 1. Teams executed well, despite operational headwinds from lingering supply chain and logistics delays, lockdowns in China and conflict in Europe. a. 2. Again saw good demand for differentiated high-value scientific instruments and life science solutions. 3Q22, Scientific Instruments segment book-to-bill ratio was again greater than 1. a. 3. With a strong 3Q, Co. has now made up for its somewhat weaker 2Q, Co. experienced some revenue delays due to supply chain and logistics. 4. Reported revenues increased 4.9% YoverY to $638.9m, despite a very strong currency headwind of minus 9%. On an organic basis, revenues increased 12.7%, which included 12% organic growth in Scientific Instruments and 20.3% organic growth at BEST, net of intercompany eliminations, while growth from acquisitions added 1.2%. a. i. This implies a constant exchange rate growth of 13.9%...
